Neurological
Developing a Magnetic Resonance Imaging Biomarker for Parkinson's
Parkinson’s disease (PD) is a progressive, neurodegenerative disorder characterised by the motor symptoms of resting tremor, rigidity, slowness of movement and poor balance. At the time these symptoms first emerge, and the clinical diagnosis of PD can be made, approximately 70% of the dopaminergic brain cells have already been irreversibly lost. Loss of these brain cells, which are critical for movement generation, may begin 5-15 years prior to the onset of first motor symptoms. Early treatment intervention is likely to ...
GO TO STUDY